CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31
COMPASS Pathways plc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$11.11+0.36 (+3.35%)
Close on Oct 19, 2026
- Market cap
- $1.50B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
66.0%
91M of 138M shares
Institutional holders
223
63 new, 29 sold out
Net institutional buying
-2M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| RTW Investments, LP | 9,474,397 | 9.90% | 13G (passive) amendment | Jun 30, 2025 |
| David Kroin | 9,274,589 | 9.99% | 13G (passive) | Jan 10, 2025 |
| Vivo Opportunity Fund Holdings, L.P. | 6,348,988 | 6.60% | 13G (passive) amendment | Mar 31, 2025 |
| Wilmot B. Harkey | 5,934,315 | 6.23% | 13G (passive) | Jun 30, 2025 |
| ATAI Life Sciences N.V. | 5,785,774 | 6.00% | 13D (active) amendment | Oct 27, 2025 |
| Roderick Wong | 12,971,571 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CMPS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 12,161,496 | 8.78% | $172.09M | – | 2.50% |
| Rtw Investments, LP | 10,700,974 | 7.73% | $151.42M | +68,584 | 1.29% |
| BIT Capital GmbH | 6,348,797 | 4.58% | $89.84M | +2,857,563 | 2.66% |
| Tang Capital Management LLC | 5,000,000 | 3.61% | $70.75M | +997,800 | 3.21% |
| Two Sigma Investments, LP | 4,470,485 | 3.23% | $63.26M | +1,886,986 | 0.05% |
| Marshall Wace, Llp | 4,328,682 | 3.13% | $61.25M | +290,347 | 0.05% |
| ARK Investment Management LLC | 3,451,965 | 2.49% | $48.85M | +150,915 | 0.32% |
| Point72 Asset Management, L.P. | 2,620,878 | 1.89% | $37.09M | New | 0.04% |
| Logos Global Management LP | 2,250,000 | 1.62% | $31.84M | New | 1.37% |
| Eagle Health Investments LP | 2,060,427 | 1.49% | $29.16M | – | 4.83% |
| Bank Of America Corp /De/ | 2,019,348 | 1.46% | $28.57M | +1,987,016 | 0.00% |
| DAFNA Capital Management LLC | 2,011,952 | 1.45% | $28.47M | −406,930 | 5.43% |
| NEXTBio Capital Management LP | 1,775,759 | 1.28% | $25.13M | −245,648 | 11.56% |
| Kalehua Capital Management LLC | 1,639,384 | 1.18% | $23.20M | – | 7.40% |
| UBS Group AG | 1,482,470 | 1.07% | $20.98M | −372,600 | 0.00% |
| Aisling Capital Management LP | 1,432,336 | 1.03% | $20.27M | – | 4.30% |
| Renaissance Technologies LLC | 1,431,889 | 1.03% | $20.26M | +566,535 | 0.03% |
| Candriam S.C.A. | 1,274,278 | 0.92% | $18.01M | New | 0.08% |
| Woodline Partners LP | 1,086,004 | 0.78% | $15.37M | +910,565 | 0.05% |
| Citadel Advisors LLC | 1,004,880 | 0.73% | $14.22M | +735,391 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 223 | 91M | 66.0% | 63 / 73 | 48 / 29 | 24M | 26M |
| Q1 2026 | 193 | 93M | 67.4% | 53 / 71 | 26 / 25 | 48M | 10M |
| Q4 2025 | 168 | 55M | 39.7% | 37 / 37 | 40 / 25 | 12M | 12M |
| Q3 2025 | 157 | 55M | 40.1% | 38 / 49 | 24 / 19 | 17M | 13M |
| Q2 2025 | 140 | 52M | 37.5% | 25 / 35 | 39 / 19 | 13M | 13M |
| Q1 2025 | 135 | 52M | 37.5% | 23 / 39 | 27 / 19 | 26M | 5M |
| Q4 2024 | 132 | 31M | 22.3% | 32 / 28 | 27 / 30 | 10M | 11M |
| Q3 2024 | 130 | 33M | 23.7% | 24 / 27 | 29 / 15 | 8M | 5M |
| Q2 2024 | 122 | 30M | 21.4% | 22 / 30 | 20 / 14 | 5M | 3M |
| Q1 2024 | 116 | 28M | 19.9% | 19 / 26 | 26 / 26 | 8M | 3M |
| Q4 2023 | 126 | 23M | 16.6% | 34 / 21 | 30 / 21 | 4M | 3M |
| Q3 2023 | 113 | 22M | 16.1% | 30 / 21 | 18 / 12 | 15M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CMPS | Value | % of fund | As of |
|---|---|---|---|---|---|
| ARK Genomic Revolution ETF | 4,463,875 | 3.22% | $50.66M | 3.25% | Jul 31, 2026 |
| iShares Biotechnology ETF | 764,943 | 0.55% | $10.82M | 0.12% | Jun 30, 2026 |
| AdvisorShares Psychedelics ETF | 359,647 | 0.26% | $5.09M | 11.45% | Jun 30, 2026 |
| Royce Smaller-Companies Growth Fund | 178,000 | 0.13% | $2.52M | 1.06% | Jun 30, 2026 |
| Simplify Propel Opportunities ETF | 114,281 | 0.08% | $1.62M | 2.09% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | 81,279 | 0.06% | $1.15M | 0.13% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 62,962 | 0.05% | $822.28K | 0.00% | May 31, 2026 |
| Dunham Small Cap Growth Fund | 62,514 | 0.05% | $709.53K | 0.89% | Jul 31, 2026 |
| AdvisorShares Dorsey Wright ADR ETF | 61,700 | 0.04% | $873.06K | 2.09% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 60,753 | 0.04% | $859.65K | 0.02% | Jun 30, 2026 |
| ROBO Global Healthcare Technology and Innovation ETF | 56,358 | 0.04% | $639.66K | 0.93% | Jul 31, 2026 |
| Tiff Multi-Asset Fund | 30,931 | 0.02% | $437.67K | 0.03% | Jun 30, 2026 |
| Old Westbury Small & Mid Cap Strategies Fund | 30,489 | 0.02% | $346.05K | 0.00% | Jul 31, 2026 |
| Virtus Biotech Clinical Trials Etf | 25,731 | 0.02% | $292.05K | 0.63% | Jul 31, 2026 |
| ActivePassive International Equity ETF | 21,455 | 0.02% | $280.20K | 0.03% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Kabir Nath | Chief Executive Officer, Director | 361,028 | 0.26% | Aug 5, 2026 |
| Guy Goodwin | Chief Medical Officer | 8,000 | 0.01% | Mar 27, 2026 |
| Teri Loxam | Chief Financial Officer | 152,002 | 0.11% | Mar 27, 2026 |
| Jeffrey M. Jonas | Director | – | – | May 29, 2026 |
| Wayne Joseph Riley | Director | – | – | May 29, 2026 |
| Justin D. Gover | Director | – | – | May 29, 2026 |
| Kathleen Tregoning | Director | – | – | May 29, 2026 |
| Gino Santini | Director | – | – | May 29, 2026 |
| David Y. Norton | Director | 20,356 | 0.01% | May 29, 2026 |
| Robert McQuade | Director | – | – | May 29, 2026 |
| Daphne Karydas | Director | – | – | May 29, 2026 |
| Linda McGoldrick | Director | – | – | Jun 13, 2025 |
| Thomas Lonngren | Director | 89,049 | 0.06% | Jun 13, 2025 |
| Annalisa Jenkins | Director | 19,480 | 0.01% | Jun 13, 2025 |
| George Jay Goldsmith | 10% owner | 6,307,970 | 4.56% | Oct 25, 2024 |
| Ekaterina Malievskaia | 10% owner | 6,307,970 | 4.56% | Oct 25, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Kabir Nath Chief Executive Officer, Director | Aug 3, 2026 | Tax withholding | −5,962 | $11.25 | $67.07K | 361,028 |
| Teri Loxam Chief Financial Officer | Mar 26, 2026 | Award | +75,000 | – | – | 152,002 |
| Kabir Nath Chief Executive Officer, Director | Mar 26, 2026 | Award | +175,000 | – | – | 366,990 |
| Kabir Nath Chief Executive Officer, Director | Mar 11, 2026 | Tax withholding | −13,131 | $6.89 | $90.47K | 191,990 |
| Teri Loxam Chief Financial Officer | Mar 11, 2026 | Tax withholding | −1,781 | $6.89 | $12.27K | 77,002 |
| Teri Loxam Chief Financial Officer | Mar 2, 2026 | Tax withholding | −4,467 | $7.02 | $31.36K | 78,783 |
| Kabir Nath Chief Executive Officer, Director | Feb 2, 2026 | Tax withholding | −16,181 | $6.61 | $106.96K | 205,121 |
| Kabir Nath Chief Executive Officer, Director | Aug 1, 2025 | Tax withholding | −6,366 | $4.34 | $27.63K | 221,302 |
| Kabir Nath Chief Executive Officer, Director | Mar 11, 2025 | Award | +92,000 | – | – | 227,668 |
| Teri Loxam Chief Financial Officer | Mar 11, 2025 | Award | +25,000 | – | – | 83,250 |
| Teri Loxam Chief Financial Officer | Mar 3, 2025 | Tax withholding | −4,468 | $3.67 | $16.40K | 58,250 |
| Kabir Nath Chief Executive Officer, Director | Feb 3, 2025 | Tax withholding | −15,516 | $4.31 | $66.87K | 135,668 |
| Ekaterina Malievskaia 10% owner | Oct 24, 2024 | Sale | −776,565 | – | – | 3,155,122 |
| Ekaterina Malievskaia 10% owner | Oct 24, 2024 | Sale | −776,565 | – | – | 3,152,848 |
| George Jay Goldsmith 10% owner | Oct 24, 2024 | Sale | −776,565 | – | – | 3,152,848 |
| George Jay Goldsmith 10% owner | Oct 24, 2024 | Sale | −776,565 | – | – | 3,155,122 |
| Life Sciences AG ATAI 10% owner | Sep 26, 2024 | Sale | −2,660,000 | $6.05 | $16.09M | 6,905,774 |
| Kabir Nath Chief Executive Officer, Director | Aug 1, 2024 | Tax withholding | −7,064 | $6.88 | $48.60K | 151,184 |
| Annalisa Jenkins Director | Aug 1, 2024 | Tax withholding | −161 | $6.88 | $1.11K | 19,480 |
| Ekaterina Malievskaia 10% owner | May 21, 2024 | Sale(10b5-1 plan) | −8,900 | $7.91 | $70.40K | 3,931,687 |
| Ekaterina Malievskaia 10% owner | May 21, 2024 | Sale(10b5-1 plan) | −8,900 | $7.91 | $70.40K | 3,929,413 |
| George Jay Goldsmith 10% owner | May 21, 2024 | Sale(10b5-1 plan) | −8,900 | $7.91 | $70.40K | 3,929,413 |
| George Jay Goldsmith 10% owner | May 21, 2024 | Sale(10b5-1 plan) | −8,900 | $7.91 | $70.40K | 3,931,687 |
| Ekaterina Malievskaia 10% owner | May 20, 2024 | Sale(10b5-1 plan) | −6,703 | $7.89 | $52.89K | 3,940,587 |
| Ekaterina Malievskaia 10% owner | May 20, 2024 | Sale(10b5-1 plan) | −6,704 | $7.89 | $52.89K | 3,938,313 |
| George Jay Goldsmith 10% owner | May 20, 2024 | Sale(10b5-1 plan) | −6,704 | $7.89 | $52.89K | 3,938,313 |
| George Jay Goldsmith 10% owner | May 20, 2024 | Sale(10b5-1 plan) | −6,703 | $7.89 | $52.89K | 3,940,587 |
| George Jay Goldsmith 10% owner | May 3, 2024 | Sale(10b5-1 plan) | −18,762 | $8.82 | $165.48K | 3,947,290 |
| George Jay Goldsmith 10% owner | May 3, 2024 | Sale(10b5-1 plan) | −18,761 | $8.82 | $165.47K | 3,945,017 |
| Ekaterina Malievskaia 10% owner | May 3, 2024 | Sale(10b5-1 plan) | −18,762 | $8.82 | $165.48K | 3,947,290 |
| Ekaterina Malievskaia 10% owner | May 3, 2024 | Sale(10b5-1 plan) | −18,761 | $8.82 | $165.47K | 3,945,017 |
| George Jay Goldsmith 10% owner | May 2, 2024 | Sale(10b5-1 plan) | −9,621 | $8.29 | $79.76K | 3,966,052 |
| George Jay Goldsmith 10% owner | May 2, 2024 | Sale(10b5-1 plan) | −9,622 | $8.29 | $79.77K | 3,963,778 |
| Ekaterina Malievskaia 10% owner | May 2, 2024 | Sale(10b5-1 plan) | −9,622 | $8.29 | $79.77K | 3,963,778 |
| Ekaterina Malievskaia 10% owner | May 2, 2024 | Sale(10b5-1 plan) | −9,621 | $8.29 | $79.76K | 3,966,052 |
| Annalisa Jenkins Director | May 1, 2024 | Tax withholding | −211 | $8.48 | $1.79K | 19,641 |
| George Jay Goldsmith 10% owner | Apr 17, 2024 | Sale(10b5-1 plan) | −10,850 | $8.78 | $95.26K | 3,975,673 |
| George Jay Goldsmith 10% owner | Apr 17, 2024 | Sale(10b5-1 plan) | −10,850 | $8.78 | $95.26K | 3,973,400 |
| Ekaterina Malievskaia 10% owner | Apr 17, 2024 | Sale(10b5-1 plan) | −10,850 | $8.78 | $95.26K | 3,975,673 |
| Ekaterina Malievskaia 10% owner | Apr 17, 2024 | Sale(10b5-1 plan) | −10,850 | $8.78 | $95.26K | 3,973,400 |
| George Jay Goldsmith 10% owner | Apr 16, 2024 | Sale(10b5-1 plan) | −23,880 | $8.53 | $203.70K | 3,984,250 |
| George Jay Goldsmith 10% owner | Apr 16, 2024 | Sale(10b5-1 plan) | −23,881 | $8.53 | $203.70K | 3,986,523 |
| Ekaterina Malievskaia 10% owner | Apr 16, 2024 | Sale(10b5-1 plan) | −23,881 | $8.53 | $203.70K | 3,986,523 |
| Ekaterina Malievskaia 10% owner | Apr 16, 2024 | Sale(10b5-1 plan) | −23,880 | $8.53 | $203.70K | 3,984,250 |
| George Jay Goldsmith 10% owner | Apr 1, 2024 | Sale(10b5-1 plan) | −25,750 | $8.96 | $230.72K | 4,010,404 |
| George Jay Goldsmith 10% owner | Apr 1, 2024 | Sale(10b5-1 plan) | −25,750 | $8.96 | $230.72K | 4,008,130 |
| Ekaterina Malievskaia 10% owner | Apr 1, 2024 | Sale(10b5-1 plan) | −25,750 | $8.96 | $230.72K | 4,010,404 |
| Ekaterina Malievskaia 10% owner | Apr 1, 2024 | Sale(10b5-1 plan) | −25,750 | $8.96 | $230.72K | 4,008,130 |
| George Jay Goldsmith 10% owner | Mar 28, 2024 | Sale(10b5-1 plan) | −25,750 | $8.65 | $222.74K | 4,036,154 |
| George Jay Goldsmith 10% owner | Mar 28, 2024 | Sale(10b5-1 plan) | −25,750 | $8.65 | $222.74K | 4,033,880 |
| Ekaterina Malievskaia 10% owner | Mar 28, 2024 | Sale(10b5-1 plan) | −25,750 | $8.65 | $222.74K | 4,036,154 |
| Ekaterina Malievskaia 10% owner | Mar 28, 2024 | Sale(10b5-1 plan) | −25,750 | $8.65 | $222.74K | 4,033,880 |
| George Jay Goldsmith Director, 10% owner | Mar 13, 2024 | Sale(10b5-1 plan) | −17,203 | $10.80 | $185.79K | 4,061,904 |
| George Jay Goldsmith Director, 10% owner | Mar 13, 2024 | Sale(10b5-1 plan) | −17,203 | $10.80 | $185.79K | 4,059,630 |
| Ekaterina Malievskaia Director, 10% owner | Mar 13, 2024 | Sale(10b5-1 plan) | −17,203 | $10.80 | $185.79K | 4,059,630 |
| Ekaterina Malievskaia Director, 10% owner | Mar 13, 2024 | Sale(10b5-1 plan) | −17,203 | $10.80 | $185.79K | 4,061,904 |
| George Jay Goldsmith Director, 10% owner | Mar 12, 2024 | Sale(10b5-1 plan) | −15,740 | $10.58 | $166.53K | 4,079,107 |
| George Jay Goldsmith Director, 10% owner | Mar 12, 2024 | Sale(10b5-1 plan) | −15,740 | $10.58 | $166.53K | 4,076,833 |
| Ekaterina Malievskaia Director, 10% owner | Mar 12, 2024 | Sale(10b5-1 plan) | −15,740 | $10.58 | $166.53K | 4,076,833 |
| Ekaterina Malievskaia Director, 10% owner | Mar 12, 2024 | Sale(10b5-1 plan) | −15,740 | $10.58 | $166.53K | 4,079,107 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Annalisa Jenkins Former Director | Aug 10, 2026 | 26,000 | $345.80K | Aug 10, 2026 | Stock Option Exercise |
| Annalisa Jenkins Former Director | Aug 7, 2026 | 83,771 | $1.15M | Aug 7, 2026 | Stock Option Exercise |
| J. Goldsmith George Other: CEO & Co-founder | Mar 13, 2024 | 432,291 | $4.61M | Mar 13, 2024 | Founder's Shares |
| Malievskaia Ekaterina Other: CIO & Co-founder | Mar 13, 2024 | 432,290 | $4.61M | Mar 13, 2024 | Founder's Shares |
| J. Goldsmith George Other: CEO & Co-founder | Dec 13, 2023 | 309,000 | $2.22M | Dec 13, 2023 | Founder's Shares |
| Malievskaia Ekaterina Other: CIO & Co-founder | Dec 13, 2023 | 309,000 | $2.22M | Dec 13, 2023 | Founder's Shares |